Involvement of GABA(A) and GABA(B) receptors in the mediation of discriminative stimulus effects of γ-hydroxybutyric acid

Physiology and Behavior

Volumn 64, Issue 3, 1998, Pages 293-302

  Colombo, Giancarlo ^a   Agabio, Roberta ^b   Lobina, Carla ^b   Reali, Roberta ^b   Gessa, Gian Luigi ^b  

^a CNR   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Baclofen; CGP 35348; Compound stimulus; Diazepam; Discriminative stimulus effects; Dizocilpine; Drug discrimination; GABA(B) and GABA(A) receptors; Rat; WIN 55,212 2; Hydroxybutyric acid (GHB)

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 HYDROXYBUTYRIC ACID; BACLOFEN; DIAZEPAM; DIZOCILPINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULUS;

EID: 0032096570     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(98)00062-6     Document Type: Article

References (49)

1. Addolorato G., Castelli E., Stefanini G.F., Casella G., Caputo F., Marsigli L., Bernardi M., Gasbarrini G. An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. Alcohol Alcohol. 31:1996;341-345.
2. Addolorato G., Cibin M., Capristo E., Beghè F., Gessa G.L., Stefanini G.F., Gasbarrini G. Maintaining abstinence from alcohol with γ-hydroxybutyric acid. The Lancet. 351:1998;38.
3. B) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB) A possible mechanism for the generation of absence-like seizures induced by GHB . J. Pharmacol. Exp. Ther. 273:1995;1534-1543.
4. Beardsley P.M., Balster R.L., Harris L.S. Evaluation of the discriminative stimulus and reinforcing effects of gammahydroxybutyrate (GHB). Psychopharmacology. 127:1996;315-322.
5. B receptors . J. Neural Transm. 35:(Suppl.):1992;155-177.
6. Cash C.D. Gammahydroxybutyrate: An overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent. Neurosci. Biobehav. Rev. 18:1994;291-304.
7. Colombo G., Agabio R., Bourguignon J., Fadda F., Lobina C., Maitre M., Reali R., Schmitt M., Gessa G.L. Blockade of the discriminative stimulus effects of γ-hydroxybutyric acid (GHB) by the GHB receptor antagonist NCS-382. Physiol. Behav. 58:1995;587-590.
8. Colombo G., Agabio R., Lobina C., Reali R., Fadda F., Gessa G.L. Symmetrical generalization between the discriminative stimulus effects of gamma-hydroxybutyric acid and ethanol: Occurrence within narrow dose ranges. Physiol. Behav. 57:1995;105-111.
9. Colombo G., Agabio R., Balaklievskaia N., Lobina C., Reali R., Fadda F., Gessa G.L. T-maze and food-reinforcement: An inexpensive drug discrimination procedure. J. Neurosci. Methods. 67:1996;83-87.
10. Colpaert F.C. Drug discrimination Behavioral, pharmacological, and molecular mechanisms of discriminative stimulus effects . Goldberg S.R., Stolerman I.P. Behavioral Analysis of Drug Dependence. 1986;161-193 Academic Press, London.
11. Czuczwar S.J., Chmielewaska B., Turski W.A., Kleinrok Z. Differential effects of baclofen, γ-hydroxybutyric acid and muscimol on the protective action of phenobarbital and diphenylhydantoin against maximal electroshock-induced seizures in mice. Neuropharmacology. 23:1984;159-163.
12. Da Prada M., Keller H.H. Baclofen and γ-hydroxybutyrate. Similar effects on cerebral dopamine neurones. Life Sci. 19:1976;1253-1264.
13. B-receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 348:1993;491-497.
14. Gallimberti L., Canton G., Gentile N., Ferri M., Cibin M., Ferrara S.D., Fadda F., Gessa G.L. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. The Lancet. 2:1989;787-789.
15. Gallimberti L., Ferri M., Ferrara S.D., Fadda F., Gessa G.L. Gamma-hydroxybutyric acid in the treatment of alcohol dependence: A double-blind study. Alcoholism: Clin. Exp. Res. 16:1992;673-676.
16. Garcha H.S., Stolerman I.P. Discrimination of a drug mixture in rats Role of training dose, and specificity . Behav. Pharmacol. 1:1989;25-31.
17. Godbout R., Jelenic P., Labrie C., Schmitt M., Bouguignon J.-J. Effect of gamma-hydroxybutyrate and its antagonist NCS-382 on spontaneous cell firing in the prefrontal cortex of the rat. Brain Res. 673:1995;157-160.
18. Goudie A.J., Leathley M.J. Drug-discrimination assays. Sahgal A. Behavioural Neuroscience A Practical Approach . II:1993;145-167 IRL Press, Oxford.
19. B binding that is blocked by valproate and ethosuximide. J. Pharmacol. Exp. Ther. 281:1997;753-760.
20. Hoes M.J.A.J.M., Vree T.B., Guelen P.J.M. Gamma-hydroxybutyric acid as hypnotic. L'Encéphale. 6:1980;93-99.
21. Holtzman S.G. Discriminative stimulus effects of drugs Relationship to potential for abuse . Adler M.W., Cowan A. Modern Methods in Pharmacology. 6:1990;193-210 Wiley-Liss, Testing and Evaluation of Drugs of Abuse. New York.
22. B receptor in cultured cerebellar granule cells. J. Neurochem. 65:1995;75-83.
23. Laborit H. Sodium 4-hydroxybutyrate. Int. J. Neuropharm. 3:1964;433-452.
24. Lammers G.J., Arends J., Declerck A.C., Ferrari M.D., Schouwink G., Troost J. Gammahydroxybutyrate and narcolepsy A double-blind placebo-controlled study . Sleep. 1993;216-220.
25. Liu Z., Snead O.C. III, Vergnes M., Depaulis A., Marescaux C. Intrathalamic injections of γ-hydroxybutyric acid increase genetic absence seizures in rats. Neurosci. Lett. 125:1991;19-21.
26. Maitre M. The γ-hydroxybutyrate signalling system in brain: Organization and functional implications. Prog. Neurobiol. 51:1997;337-361.
27. Maitre M., Hechler V., Vayver P., Gobaille S., Cash C.D., Schmitt M., Bourguignon J.-J. A specific γ-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties. J. Pharmacol. Exp. Ther. 255:1990;657-663.
28. Mamelak M., Escriu J.M., Stokan O. The effects of γ-hydroxybutyrate on sleep. Biol. Psychiat. 12:1977;273-288.
29. Mamelak M., Webster P. Treatment of narcolepsy and sleep apnea with gammahydroxybutyrate: A clinical and polysomnographic case study. Sleep. 4:1981;105-111.
30. Mariathasan E.A., Garcha H.S., Stolerman I.P. Discriminative stimulus effects of amphetamine and pentobarbitone separately and as mixture in rats. Behav. Pharmacol. 2:1991;405-415.
31. Mariathasan E.A., Stolerman I.P. Overshadowing of nicotine drug discrimination in rats: A model for behavioural mechanisms of drug interactions? Behav. Pharmacol. 4:1993;209-215.
32. Nimmerrichter A.A., Beckmann E., Gazsó E., Mader R., Marx B., Plech A., Puchinger H., Saletu M., Lesch O.M. Double-blind controlled trial of GHB in two dosages and chlormethiazole in the treatment of alcohol withdrawal syndrome. Alcoholism: Clin. Exp. Res. 21:(Suppl.):1997;32A.
33. B-receptor antagonist, CGP 35348, antagonizes γ-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice. J. Neural Transm. 103:1996;1255-1263.
34. Olsen R.W., Bergman R.O., Van Ness P.C., Lummis S.C., Watkins A.E., Napias C., Greenlee D.V. γ-Aminobutyric acid receptor binding in mammalian brain. Heterogeneity of binding sites. Mol. Pharmacol. 19:1981;217-227.
35. Overton D.A. Application and limitations of the drug discrimination method for the study of drug abuse. Colpaert F.C., Slanger J.L. Drug Discrimination: Applications in CNS Pharmacology. 1982;291-340 Elsevier, Amsterdam.
36. Pertwee R.G. Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors: An overview. Pertwee R.G. Cannabinoid Receptors. 1995;1-34 Academic Press, London.
37. Schmidt C., Gobaille S., Hechler V., Schmitt M., Bourguignon J.-J., Maitre M. Anti-sedative and anti-cataleptic properties of NCS-382, a γ-hydroxybutyrate receptor antagonist. Eur. J. Pharmacol. 203:1991;393-397.
38. Scrima L., Hartman P.G., Johnson F.H. Jr, Thomas E.E., Hiller F.C. The effects of γ-hydroxybutyrate on the sleep of narcolepsy patients: A double-blind study. Sleep. 13:1990;479-490.
39. B and γ-hydroxybutyric acid receptor antagonists. Pharmacol. Biochem. Behav. 53:1996;73-79.
40. B) receptor in rat brain. Biochem. Pharmacol. 52:1996;1235-1243.
41. Stolerman I.P., Mariathasan E.A. Discrimination of an amphetamine-pentobarbitone mixture by rats in an AND-OR paradigm. Psychopharmacology. 102:1990;557-560.
42. Stolerman I.P., Rauch R., Norris E.A. Discriminative stimulus effects of a nicotine-midazolam mixture in rats. Psychopharmacology. 93:1987;250-256.
43. Tunnicliff G. Significance of γ-hydroxybutyric acid in the brain. Gen. Pharmac. 23:1992;1027-1034.
44. Waldmeier P.C., Fehr B. Effects of baclofen and γ-hydroxybutyrate on rat striatal mesolimbic 5-HT metabolism. Eur. J. Pharmacol. 49:1978;177-184.
45. White J.-A.W., Stolerman I.P. Antagonism of a nicotine plus midazolam discriminative cue in rats. Behav. Pharmacol. 5:1994;351-355.
46. B receptor-mediated hyperpolarization. Neuroscience. 66:1995;133-141.
47. Winter J.C. The stimulus properties of gamma-hydroxybutyrate. Psychopharmacology. 73:1981;371-375.
48. Wong E.H.F., Kemp J.A. Sites for antagonism on the N-methyl-D-aspartate receptor channel complex. Ann. Rev. Pharmacol. Toxicol. 31:1991;401-425.
49. B receptors. Eur. J. Pharmacol. 212:1992;291-294.